Quick Answer
Can-Fite BioPharma Ltd. reported Net Income of -$9.83 million for fiscal year 2025.
Can-Fite BioPharma Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$9.83M | -24.7% |
| 2024 | -$7.88M | -3.2% |
| 2023 | -$7.63M | +25.0% |
| 2022 | -$10.17M | +19.4% |
| 2021 | -$12.62M | +12.7% |
| 2020 | -$14.44M | -14.4% |
| 2019 | -$12.62M | -92.1% |
| 2018 | -$6.57M | — |
- Can-Fite BioPharma Ltd. showed a decrease of -24.7% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Can-Fite BioPharma Ltd.’s net income has declined by 49.6% (from -$6.57 million to -$9.83 million).
- The most recent figure is from Can-Fite BioPharma Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: